$1.41
-0.07-4.73%
At Close: -
$1.35
-0.06-4.26%
After Hours: 6:51 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Nektar Therapeutics in recent months.
Browse guidance and forecast on all stocks.